^

Bansa

Antibiotic pinababawi ng FDA

Doris Franche-Borja - Pilipino Star Ngayon

MANILA, Philippines - Pinababawi ng Food and Drugs Administration (FDA) sa merkado ng ilang batch ng isang antibiotic matapos hindi makasunod sa tamang specifications.

Sa advisory ng FDA, pinababawi nito sa merkado ang Rifampicin na may brand name na Rifanid 200 milligram per 5 milliliter suspension (200 mg/5ml) na may batch numbers C30002, C30007, at C30008 na mae-expire sa May at July 2016.

Lumitaw sa pagsusuri na hindi agad natutunaw ang powder sa tubig at nagbubuo-buo ito kahit pa ito kalugin.

Ang Rifampicin Suspension ay ginagamit na panlunas sa TB, leprosy, at iba pang impeksyon.

vuukle comment

ANG

ANG RIFAMPICIN SUSPENSION

BATCH

DRUGS ADMINISTRATION

FDA

HINDI

ITO

LUMITAW

MERKADO

PINABABAWI

RIFANID

Philstar
x
  • Latest
Latest
Latest
abtest
Recommended
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with